Literature DB >> 8980727

Primary spinal column sarcomas.

E Tasdemiroglu1, E Bagatur, I Ayan, E Darendeliler, R A Patchell.   

Abstract

Five cases of primary spinal column sarcomas are presented. Sarcomas primarily originating from paravertebral soft tissues were excluded. Patients' age ranged from 1 to 14 years (mean 8.4 years). The male:female ration was 2:3. Two patients had Ewing's sarcoma (ES) originating from L5-S1 and L4-5 pedicles, respectively; two patients had mesenchymal chondrosarcoma (MCS) originating from L1-2 pedicles and L5 body, respectively; and one patient had osteogenic sarcoma (OS) of C4 body. All patients clinically presented with pain and progressive weakness of the extremities. The time that elapsed between the onset of symptoms and diagnoses ranged from one to five months. All cases were treated with chemotherapy, radiotherapy and subtotal tumour resection with spinal canal decompression. Two cases received posterior spinal fusion operations. Three patients were alive 10 to 98 months following diagnosis. Only the case with ES of L5-S1 pedicles was in complete remission and off therapy at the 98th postoperative month. The two MCS cases were in partial remission, and were receiving chemotherapy at the time of analysis. These tumours caused similar clinical findings and prognoses, and required combined treatment, which consisted of surgery, radiotherapy and chemotherapy; histologically three different types of malignant tumours are presented in the same category. We preferred surgical decompression and stabilization procedures especially for neurologically symptomatic patients, even if they had extensive tumours with high grades. By spinal canal decompression and stabilisation, we did not intend to cure the disease; however, we intended to provide neurological improvement, spinal stabilisation, improved quality of life, early mobilisation of the patient, and cytoreduction by means of surgical tumour ablation, which could render the chemotherapy more effective.

Entities:  

Mesh:

Year:  1996        PMID: 8980727     DOI: 10.1007/bf01411053

Source DB:  PubMed          Journal:  Acta Neurochir (Wien)        ISSN: 0001-6268            Impact factor:   2.216


  14 in total

1.  Unusual benign and malignant chondroid tumors of bone. A survey of some mesenchymal cartilage tumors and malignant chondroblastic tumors, including a few multicentric ones, as well as many atypical benign chondroblastomas and chondromyxoid fibromas.

Authors:  L LIGHTENSTEIN; D BERNSTEIN
Journal:  Cancer       Date:  1959 Nov-Dec       Impact factor: 6.860

2.  Primary osteogenic sarcoma of the cervical spine. A case report.

Authors:  J W Fielding; V G Fietti; J E Hughes; J C Gabrielian
Journal:  J Bone Joint Surg Am       Date:  1976-09       Impact factor: 5.284

3.  Primary osteogenic sarcoma of the cervical spine originally mistaken for benign osteoblastoma. A case report.

Authors:  H O Marsh; C B Choi
Journal:  J Bone Joint Surg Am       Date:  1970-10       Impact factor: 5.284

4.  Ewing's sarcoma of the vertebral column.

Authors:  M V Pilepich; T J Vietti; M E Nesbit; M Tefft; J Kissane; O Burgert; D Prichard; E A Gehan
Journal:  Int J Radiat Oncol Biol Phys       Date:  1981-01       Impact factor: 7.038

5.  Primary osteosarcoma of the cervical spine: one case.

Authors:  K Ben Miled; M Siala; K R Hamza; H Rais; T Ben Rhouma; M Kammoun; R Hamza
Journal:  J Neuroradiol       Date:  1988       Impact factor: 3.447

6.  Primary Ewing's sarcoma of the spine.

Authors:  M R Grubb; B L Currier; D J Pritchard; M J Ebersold
Journal:  Spine (Phila Pa 1976)       Date:  1994-02-01       Impact factor: 3.468

7.  Central nervous system mesenchymal chondrosarcoma. Case report.

Authors:  G R Harsh; C B Wilson
Journal:  J Neurosurg       Date:  1984-08       Impact factor: 5.115

8.  Combined treatment of osteosarcoma of the spine.

Authors:  N Sundaresan; G Rosen; A G Huvos; G Krol
Journal:  Neurosurgery       Date:  1988-12       Impact factor: 4.654

9.  Vertebral osteosarcoma.

Authors:  D Tigani; G Pignatti; P Picci; R Savini; M Campanacci
Journal:  Ital J Orthop Traumatol       Date:  1988-03

10.  Osteosarcoma of the spine.

Authors:  T C Shives; D C Dahlin; F H Sim; D J Pritchard; J D Earle
Journal:  J Bone Joint Surg Am       Date:  1986-06       Impact factor: 5.284

View more
  7 in total

Review 1.  Multidisciplinary management of primary tumors of the vertebral column.

Authors:  Wesley Hsu; Thomas A Kosztowski; Hasan A Zaidi; Michael Dorsi; Ziya L Gokaslan; Jean-Paul Wolinsky
Journal:  Curr Treat Options Oncol       Date:  2009-06-23

2.  Case report: Mesenchymal chondrosarcoma of the lumbar spine in a child.

Authors:  Aristidis H Zibis; M Wade Shrader; Lee S Segal
Journal:  Clin Orthop Relat Res       Date:  2010-03-19       Impact factor: 4.176

3.  Primary Spinal Intradural Mesenchymal Chondrosarcoma with Several Local Regrowths Treated with Osteoplastic Laminotomies: A Case Report.

Authors:  Marek Derenda; Damian Borof; Ireneusz Kowalina; Wojciech Wesołowski; Wojciech Kloc; Ewa Iżycka-Świeszewska
Journal:  Surg J (N Y)       Date:  2017-07-20

4.  Multiple Loose Bodies in the Lumbar Facet Joint: Case Report.

Authors:  Yuhei Yamasaki; Fumitake Tezuka; Kazuta Yamashita; Yoichiro Takata; Toshinori Sakai; Toru Maeda; Koichi Sairyo
Journal:  NMC Case Rep J       Date:  2019-05-25

Review 5.  Primary osseous chondrosarcoma in the lumbar spine: case report and literature review with analysis.

Authors:  Chih-Hisu Tu; You-Pen Chiu; Hui-Ru Ji; Cheng-Di Chiu
Journal:  J Int Med Res       Date:  2021-11       Impact factor: 1.671

6.  Primary mesenchymal chondrosarcoma of the adult lumbar spine: a case report and review of the literature.

Authors:  Maoqiang Lin; Haiyu Zhou; Xiaobo Zhang; Yicun Hu; Taowen Guo; Jintao Shi
Journal:  Transl Cancer Res       Date:  2022-09       Impact factor: 0.496

7.  Revision Surgical Treatment of a Second Lumbar Ewing Sarcoma: A Report of a Rare Case.

Authors:  Helin Feng; Jin Wang; Peng Guo; Jianfa Xu; Jiangang Feng
Journal:  Medicine (Baltimore)       Date:  2015-07       Impact factor: 1.889

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.